Clinical Trial Update: C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

View source ↗

Summary

A Mayo Clinic study evaluating neuroinflammation in post-COVID syndrome using the C11 ER176 PET tracer; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• C11-ER176 PET tracer (ER176 radiotracer)

Snippet

Sponsor: Mayo Clinic | Conditions: COVID-19 | Status: NOT_YET_RECRUITING